Dr. Ferraro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 N Flamingo Rd
Ste 11
Pembroke Pines, FL 33028Phone+1 954-265-4325Fax+1 954-443-4747
Education & Training
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003- SUNY Upstate Medical UniversityResidency, Internal Medicine, 1997 - 2000
University of Buenos AiresClass of 1992
Certifications & Licensure
FL State Medical License 2003 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2006 Oct 23
- FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 5 citationsUsing cfRNA as a tool to evaluate clinical treatment outcomes in patients with metastatic lung cancers and other tumors.Luis E Raez, Kathleen Danenberg, Daniel Sumarriva, Joshua Usher, Jacob Sands
Cancer Drug Resistance. 2021-01-01
Press Mentions
Dr. Ferraro on the Use of Molecular Profiling in Pancreatic CancerJanuary 16th, 2020
Questions Remain in Localized Pancreatic Cancer as More Treatment Modalities EmergeJanuary 10th, 2020
Other Languages
- Spanish, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
